The consumer goods sector is undergoing a significant transformation, with Procter & Gamble confronting a newly emerging ...
Kenvue and Kimberly-Clark are merging in a $32B deal with $2.1B in synergies and major consumer health potential. Learn why ...
In addition to Tylenol, Kenvue production facilities roll out essential name-brand health products like Neosporin, Motrin and BAND-AID.
Texas accuses Tylenol maker of ‘fraudulent transfer’ for announcing dividends payout to shareholders
The Texas Office of Attorney General, or OAG, asked a Panola County court on Wednesday to block a Texas company from paying ...
Texas Attorney General Ken Paxton on Thursday asked a state judge to block Kenvue from paying a nearly $400 million ...
In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator, ...
No deal might be the best outcome for dividend-seeking investors. It’s a story as old as time. Two Dividend Aristocrats meet, ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...
In one of the most significant consumer-goods mergers of the year, Kimberly-Clark is buying Tylenol maker Kenvue in a ...
The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ ...
A price-sensitive, value-conscious consumer adds a degree of unevenness and uncertainty to a robust earnings season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results